期刊文献+

HPLC法测定人体血浆中利福平和异烟肼的浓度 被引量:5

HPLC Determination of Rifampicin and Isoniazid in Human Plasma
下载PDF
导出
摘要 目的:建立一种用HPLC同时测定人体血浆中利福平和异烟肼浓度的方法。方法:色谱柱为TSK-gel ODS-80(5μm,250mm×4.6mm),流动相0.02mol·L^(-1)磷酸二氢钾-乙腈-三乙胺(40:60:0.15,磷酸调pH 4.30),流速0.9mL·min^(-1),柱温30℃,检测波长为264 nm,内标为氟哌啶醇。结果:利福平和异烟肼的线性范围分别为0.25~32 mg·L^(-1)(r=0.999 8)和0.125~16 mg·L^(-1)(r=0.999 8);高、中、低3个浓度的萃取回收率分别为86.6%~91.8%和88.0%~90.2%: 日内RSD为1.1%~9.0%和1.6%~4.2%,日间RSD为1.2%~8.2%和2.9%~7.2%,n=5。结论:方法简便、准确,可为利福平复方制剂药代动力学研究提供—理想的检测方法。 Objective: To establish a HPLC method for determining rifampicin and isoniazid in human plasma. Methods: The HPLC system consisted of TSK - gel ODS - 80 (250 mm×4. 6 mm, 5μm) column, 0.02 mol · L-1 KH2PO4 - acetonitrile - triethylamine (40: 60: 0. 15 , adjust pH to 4. 30 with H3PO4 ) as mobile phase, flow rate was 0. 9 mL · min-1 , column temperature was 30℃ with detection at 264 nm, and the internal standard was haloperidol. Results: The linear ranges of rifampicin and isoniazid were 0. 25 - 32 mg· L-1 ( r = 0. 999 8 ) and 0. 125- 16 mg· L-1 ( r = 0. 999 8), respectively. The extraction recoveries were 86.6% -91.8% and 88.0%-90.2% (n=5). The RSD of intra - day were 1. 1 % - 9. 0% and 1. 6% - 4. 2% ( n =5 ) ; the RSD of inter - day is 1.2% -8.2% and 2.9% -7.2% (n =5). Conclusion: The method is accurate and simple for the pharmacokinetics research of rifampicin compound preparation.
出处 《药物分析杂志》 CAS CSCD 北大核心 2002年第5期358-360,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 血浆 利福平 异烟肼 高效液相色谱法 血药浓度 测定 HPLC, rifampicin, isoniazid, plasma concentration
  • 相关文献

参考文献1

二级参考文献4

共引文献11

同被引文献32

  • 1金鸣,黄河,蔡向阳,吴贵宝,李玲,杨德隆.异烟肼在急性中毒家兔体内的分布[J].中国医院药学杂志,2004,24(5):258-260. 被引量:2
  • 2黎拒难,高朋,李湘玲,严志红,毛勋.芦荟大黄素在碳糊电极上的吸附催化伏安法研究[J].中国科学(B辑),2005,35(1):38-43. 被引量:4
  • 3倪福英,魏荣.紫外分光光度法测定人血清中利福平浓度[J].药物分析杂志,1995,15(A01):209-210. 被引量:1
  • 4杨丽斌,姜晓莉.双波长紫外—可见分光光度法测定复方利福平眼液的含量[J].药物分析杂志,1995,15(A01):426-427. 被引量:1
  • 5Ezung T, Devi NT, Singh NT, et al. Pulmonary tuberculosis and diabetsmellitus-a study[J]. J Indian Med Assoe, 2002, 100(6): 376-379.
  • 6Mugusi F, Swai, Albertl,et al. Increased prevalence of diabetes mellituss in patients with pulmonary tuberculosis in Tnzania [J]. Tubercle, 1990,71 : 271-276.
  • 7Bashar M, Alcabes P, Rom WN, et al. Increased incidence of multidug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997 [J]. Chest, 2001,120 (5) : 1514-1519.
  • 8Kim SJ, HongYP, Lew EJ, et al. Incidence of pulmonary tuberculosis among diabetics[J]. Tubercle and lung disease, 1995, 76 : 529-533.
  • 9Feleke Y, Abdulkadir J, Aderaye G. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients[J]. East Africean Med J, 1999,76:361-364.
  • 10Karachunskii MA, Kaminskaia GO, Kossii IuE, et al. Features of isoniazid activation in patients with tuberculosis and diabetes mellitus[J]. Probl-Tuberk, 2001,7 : 26-27.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部